These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3905165)

  • 1. Interpretation of drug levels in acute and chronic disease states.
    Perucca E; Grimaldi R; Crema A
    Clin Pharmacokinet; 1985; 10(6):498-513. PubMed ID: 3905165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of drug levels: relevance of plasma protein binding.
    Perucca E; Richens A
    Ciba Found Symp; 1979; (74):51-68. PubMed ID: 261688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.
    Tillement JP; Albengres E; Urien S
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):123-7. PubMed ID: 393513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum drug concentrations in clinical perspective.
    Koch-Weser J
    Ther Drug Monit; 1981; 3(1):3-16. PubMed ID: 7015580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum level approach to individualization of drug dosage.
    Koch-Weser J
    Eur J Clin Pharmacol; 1975 Oct; 9(1):1-8. PubMed ID: 786685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications.
    Klotz U
    Clin Pharmacokinet; 1976; 1(3):204-18. PubMed ID: 797498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
    Greenblatt DJ; Sellers EM; Koch-Weser J
    J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of disease states on plasma protein binding of drugs.
    Reidenberg MM
    Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
    [No Abstract]   [Full Text] [Related]  

  • 11. Calculation of normalized drug concentrations in the presence of altered plasma protein binding.
    Musteata FM
    Clin Pharmacokinet; 2012 Jan; 51(1):55-68. PubMed ID: 22149258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-induced modifications of drug pharmacokinetics.
    Barre J; Houin G; Brunner F; Bree F; Tillement JP
    Int J Clin Pharmacol Res; 1983; 3(4):215-26. PubMed ID: 6381335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors contributing to variability in drug pharmacokinetics. II. Drug distribution.
    Routledge PA
    J Clin Hosp Pharm; 1985 Mar; 10(1):15-23. PubMed ID: 3889062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma drug level monitoring in pregnancy.
    Eadie MJ; Lander CM; Tyrer JH
    Clin Pharmacokinet; 1977; 2(6):427-36. PubMed ID: 589881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function.
    Reidenberg MM
    Am J Med; 1977 Apr; 62(4):466-70. PubMed ID: 851114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are plasma drug levels clinically relevant?
    Sommers DK
    S Afr Med J; 1982 Jan; 61(1):12-3. PubMed ID: 7058393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma binding of drugs in chronic renal failure].
    Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
    Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic consequences of drug displacement from blood and tissue proteins.
    MacKichan JJ
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():32-41. PubMed ID: 6705425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological role of the kidney.
    Brater DC
    Drugs; 1980 Jan; 19(1):31-48. PubMed ID: 6988197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.